Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

ICAD Stock - iCad Stock Trading


home / stock / icad

ICAD ICAD Quote ICAD Short ICAD News ICAD Articles ICAD Message Board

MWN AI Summary *

iCAD Inc. (NASDAQ: ICAD) is a prominent technology company that specializes in artificial intelligence (AI) solutions for the healthcare sector, particularly focusing on medical imaging and cancer detection. Established in 1984, iCAD has evolved from a traditional software provider to a leader in innovative cancer detection technologies that enhance the accuracy and efficiency of diagnostic imaging.

The company's flagship products include a suite of AI-powered solutions designed to assist radiologists in identifying and detecting breast cancer, as well as other forms of cancer through advanced imaging techniques. iCAD’s innovative software solutions significantly aid in detecting tumors early, which is essential for effective treatment and improved patient outcomes. Its products leverage machine learning algorithms to analyze imaging data, effectively reducing the chances of oversight by human interpreters.

In recent years, iCAD has made strides in strategic partnerships, collaborations, and clinical studies to further validate its technologies and expand its market reach. The company has also focused on acquiring CE Mark and FDA clearances for many of its advanced imaging solutions, which facilitates their adoption in various clinical settings.

Despite the challenges posed by the competitive landscape and the regulatory environment, iCAD remains committed to pushing the boundaries of cancer detection and diagnosis. Financially, the company has shown potential for growth, with analysts closely monitoring its quarterly earnings reports and guidance for future performance.

Investors are particularly interested in iCAD due to its focus on cutting-edge technology in a critical healthcare segment, as demand for improved cancer detection methods continues to rise. As the healthcare industry increasingly integrates AI into clinical workflows, iCAD Inc. positions itself as a significant player in enhancing early cancer detection and improving overall patient care.

MWN AI Analysis *

As of the latest available data, iCad Inc. (NASDAQ: ICAD) presents an intriguing investment opportunity, particularly within the healthcare and medical technology sectors. This company focuses on innovative cancer detection and treatment solutions, specifically through its advanced imaging and software technologies designed to improve diagnostic accuracy and efficacy in radiation therapy.

Key factors to consider in evaluating ICAD's market potential include its expanding product portfolio and strategic partnerships. The company's proprietary solutions, such as the ClearEdge™ software—which assists in detecting tumors—demonstrate a commitment to enhancing diagnostic processes and improving patient outcomes. Moreover, ICAD's collaborations with healthcare institutions and research organizations bolster its credibility and expand its reach within the market.

Financially, investors should monitor ICAD's revenue growth trends and expenditures related to research and development (R&D). As a technology-driven firm, maintaining a robust R&D pipeline is essential for fostering innovation and keeping pace with competitive advancements. Analysts suggest evaluating the company’s quarterly earnings reports for signs of sustained revenue growth and operational efficiency.

It's also vital to consider broader market trends, including the increasing global focus on early cancer detection and personalized medicine. These trends could drive demand for ICAD's offerings and enhance its market positioning. However, potential investors should remain cautious of market volatility and competitive pressures, particularly from larger players in the healthcare technology sector.

In summary, investing in iCad Inc. can be a rewarding opportunity if approached with due diligence. Monitoring their strategic initiatives, financial performance, and market conditions will be crucial in assessing the potential upside. As a growth-oriented company in a dynamic industry, ICAD warrants attention from investors looking to capitalize on advancements in cancer care technologies.

* MWN AI Summary and Analysis is based on asking OpenAI to summarize and analyze the company and stock symbol.


About | iCad Inc. (NASDAQ:ICAD)

icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers. Its products include powerlook tomo detection, powerlook density assessment, and vera look. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used in the treatment of non-melanoma skin cancer, early-stage breast cancer, and gynecological cancers.

Quote | iCad Inc. (NASDAQ:ICAD)

Last:$3.72
Change Percent: -2.43%
Open:$3.8
Close:$3.72
High:$3.8
Low:$3.68
Volume:141,448
Last Trade Date Time:07/08/2025 03:37:23 pm

News | iCad Inc. (NASDAQ:ICAD)

  • iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Acquisition by RadNet, Inc.

    NASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, today announced that leading independent proxy advisory firms Institutional Shareholder Serv...

    • July 08, 2025 08:00:00 am

    • |
    • GlobeNewswire
    • |
      • ICAD Stock
      • ICAD Quote
      • ICAD Short
      • ICAD News
      • ICAD Articles
      • ICAD Message Board
  • Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health

    Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable of reshaping how care is delivered, diagnosed, and managed. In the f...

    • June 17, 2025 09:54:00 am

    • |
    • Baystreet
    • |
      • ICAD Stock
      • ICAD Quote
      • ICAD Short
      • ICAD News
      • ICAD Articles
      • ICAD Message Board

Message Board Posts | iCad Inc. (NASDAQ:ICAD)

Subject By Source When
whytestocks: $ICAD News Article - iCAD's Breast AI Suite Empowers Customers to Lead the Way in Suppo whytestocks investorshangout 03/23/2023 5:10:52 PM
Looks like a new 10 year low. willlbone investorshub 03/14/2023 2:07:04 PM
$iCAD looking forward to the start of quarter Netcool investorshub 01/07/2023 11:35:56 PM
Insider buying today dletizia investorshub 01/06/2023 1:39:43 AM
On Dec. 5, U.S. stocks were dragged down dletizia investorshub 12/12/2022 3:00:27 PM

MWN AI FAQ **

What are the recent developments in technology or products that could impact iCad Inc. (NASDAQ: ICAD) in the medical imaging sector?

Recent advancements in AI-driven imaging analysis, enhanced machine learning algorithms, and the development of non-invasive imaging techniques could significantly impact iCad Inc.'s offerings and market positioning in the medical imaging sector.

Sure, please provide the question you'd like me to answer!

2. How does the financial performance of iCad Inc. (NASDAQ: ICAD) compare to its industry peers over the past year?

iCad Inc. has shown mixed financial performance over the past year compared to its industry peers, with fluctuations in revenue and stock price but demonstrating growth potential through its innovative products in the medical imaging sector.

3. What strategic partnerships has iCad Inc. (NASDAQ: ICAD) formed recently that may enhance its market position?

Recently, iCad Inc. (NASDAQ: ICAD) formed strategic partnerships with leading healthcare organizations to enhance its market position through collaborative advancements in cancer detection and treatment technologies.

4. What are analysts predicting for the future growth of iCad Inc. (NASDAQ: ICAD) in terms of revenue and market share?

Analysts predict that iCad Inc. (NASDAQ: ICAD) will experience steady growth in revenue and an increasing market share driven by its expanding cancer detection solutions and strategic partnerships in the healthcare sector.

** MWN AI Questions are based on asking OpenAI to ask and answer four questions about the company and stock symbol.

Stock Information

Get ICAD Alerts

News, Short Squeeze, Breakout and More Instantly...

iCad Inc. Company Name:

ICAD Stock Symbol:

NASDAQ Market:

-2.43% G/L:

$3.72 Last:

141,448 Volume:

$3.80 Open:

$3.72 Close:

iCad Inc. Website:

iCad Inc. Logo

Ad

Investor Relations
RECENT ICAD NEWS
  • ICAD - iCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Acquisition by RadNet, Inc.

    NASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, today announced that leading independent proxy advisory firms Institutional Shareholder Serv...

  • ICAD - Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health

    Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable of reshaping how care is delivered, diagnosed, and managed. In the f...

  • ICAD - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders

    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, LNSR, ICAD on Behalf of Shareholders PR Newswire NEW YORK , June 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violation...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get ICAD Alerts

Get ICAD Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1